“Durability of Response After Pausing Abrocitinib Treatment in Patients With Moderate-to-Severe Atopic Dermatitis”. 2025. SKIN The Journal of Cutaneous Medicine 9 (6): s600. https://doi.org/10.25251/gaabwz65.